Edition:
United Kingdom

Probi AB (PROB.ST)

PROB.ST on Stockholm Stock Exchange

322.50SEK
14 Dec 2017
Change (% chg)

-7.00kr (-2.12%)
Prev Close
329.50kr
Open
329.50kr
Day's High
329.50kr
Day's Low
322.50kr
Volume
6,946
Avg. Vol
23,590
52-wk High
613.00kr
52-wk Low
290.00kr

Summary

Name Age Since Current Position

Jean-Yves Parisot

53 2015 Chairman of the Board

Peter Nahlstedt

43 2014 Chief Executive Officer

Jorn Andreas

37 2017 Chief Financial Officer

Niklas Brandt

58 2017 Chief Information Officer

Linda Neckmar

44 2016 Vice President of Operations

Niklas Bjarum

54 Vice President of Marketing and Sales, President of Probi USA Inc.

Josefin af Petersens

40 2017 Vice President Human Resources

Gun-Britt Fransson

64 2014 Vice President of Research and Development

Scott Bush

61 2017 Independent Director

Charlotte Hansson

55 2017 Independent Director

Anna Malm Bernsten

56 2017 Independent Director

Jan Nilsson

64 2010 Independent Director

Jonny Olsson

53 2015 Independent Director

Biographies

Name Description

Jean-Yves Parisot

Dr. Jean-Yves Parisot has been Chairman of the Board of Probi Aktiebolag since April 23, 2015. He holds a Master of Business Administration degree and Doctor in Veterinary Medicine degree. He is CEO of Diana, part of Symrise Group. He is also Chairman of the Board of VetAgroSup. He previously held senior positions at Air Liquide, Danisco, Rhodia Food, Rhone-Poulenc, Merial and Pfizer.

Peter Nahlstedt

Mr. Peter Nahlstedt has been appointed Chief Executive Officer of Probi AB, effective as of January 7, 2014. He has experience from the international Life Science industry through various executive positions involving strategy, marketing and sales at GE Healthcare Life Science. He joined Probi from Trelleborg Marine Systems. In 2010, he was recruited to Trelleborg Marine Systems to take responsibility for operations in Europe, South America and North Africa. Prior to this, he spent eight years at GE Healthcare, where he was General Manager Sales and Marketing for Bioprocess in North America between 2007 and 2010 and before that Strategic Marketing Director. During his time at GE Healthcare, he held various global executive positions with a focus on strategy, marketing and sales. He also worked with sales and marketing at Sigma Aldrich. He holds Master of Science degree in Chemical Engineering and Bachelor of Science degree in Economics from Lunds universitet.

Jorn Andreas

Mr. Jorn Andreas has been appointed Chief Financial Officer of Probi AB, effective as of March 1, 2017. He was Member of the Board of Directors of the Company from April 29, 2014 until March 1, 2017. He has been Chief Integration Officer and Vice President, Finance, Symrise Aroma Molecules Division, Jacksonville, the United States. He formerly worked with The Boston Consulting Group, Hamburg, Germany and Bayer AG, Leverkusen, Germany. He holds a Doctorate in Philosophy in Economic Sciences from Karlsruhe Institute of Technology (KIT), Karlsruhe, Germany.

Niklas Brandt

Mr. Niklas Brandt has been Chief Information Officer at Probi AB since March 1, 2017. He has previously been Chief Financial Officer of the Company since May 2008. He previously worked for six years as Chief Financial Officer of Moving AB. Before that, he had a number of senior positions within finance and administration in a number of companies, such as Tibnor and EF Education. He holds a degree in Business Administration from Lunds Universitet.

Linda Neckmar

Ms. Linda Neckmar has been Vice President of Operations at Probi AB since January 2016. She holds Master of Science in Chemical Engineering from Lund University. Linda Neckmar has extensive experience from the biotechnology industry, in pharmaceutical development and international business development, marketing and sales. Linda was employed at Probi in 2011 with responsibility for Marketing and Sales Consumer Healthcare. Prior to this, she worked at BioInvent International AB and OxiGene Inc.

Niklas Bjarum

Mr. Niklas Bjarum has been Vice President of Marketing and Sales at Probi AB since February 2001 and he is President of Probi USA Inc. within the Company. After receiving hid degree in 1988, he served in a number of positions in sales, marketing and business development of both strategic and operative character in Nestle and Masterfoods (Mars Inc). In 1998, he changed sector and worked three years at Ericsson Mobile Communications with responsibility for business development in Europe. He holds a degree in International Business Administration from Lunds Universitet.

Josefin af Petersens

Ms. Josefin af Petersens has been Vice President Human Resources at PROBI Aktiebolag since May 2017. She holds a degree in Sociology from Lunds Universitet. She has over 15 years of international experience from HR positions within the pharmaceutical industry. She was recently HR Director for Danish and Norwegian subsidiaries at Novo Nordisk.

Gun-Britt Fransson

Ms. Gun-Britt Fransson has served as Vice President of Research and Development at Probi AB since January 7, 2014. Before that, she has been Acting Chief Executive Officer of the Company since May 24, 2013. Previously, she was Vice President Research and Development from February 29, 2012. She has held senior positions in the biotechnology, pharmaceutical and food industries for 20 years, most recently as Chief Executive Officer of Alligator Bioscience AB in Lund (2004-2010). Prior to that, she was active for just over ten years as Director of Research at Procordia Food AB and Orkla Foods AS. She holds Doctorate of Philosophy degree in Nutrition from Uppsala Universitet.

Scott Bush

Mr. Scott Bush has been Independent Director at PROBI Aktiebolag since May 4, 2017. He is Civil Engineer and holds Master of Science degree in Economics and Business Administration. He is Owner and CEO of Probiotic Consulting LLC. Previously, he held senior positions at DuPont, Danisco and Rhodia. He is Board Member of World Probiotic Association.

Charlotte Hansson

Ms. Charlotte G. Hansson has been Independent Director at PROBI Aktiebolag since May 4, 2017. She is CEO of MorgonTidig Distribution KB. She previously held senior positions at Jetpak Group AB, Danzas ASG Eurocargo AB and Carl Zeiss AB. She is Board Member of Orio AB, DistIT AB, BE Group AB, Momentum Group AB. She holds a degree in Biochemistry from Koebenhavns universitet and is Market Economist from IHM.

Anna Malm Bernsten

Ms. Anna Malm Bernsten has been Independent Director at PROBI Aktiebolag since May 4, 2017. She is Owner and CEO of Bernsten Konsult AB. Previously, she held senior positions at Oatly, GE Healthcare Life Sciences, ASSA ABLOY and Pharmacia & Upjohn, among others. She is Board Member of Medivir, Bjorn Axen, Cellavision and Pagen. She is Civil Engineer from Kungliga Tekniska Hogskolan.

Jan Nilsson

Mr. Jan Nilsson has been Independent Member of the Board of Directors of Probi AB since 2010. He is Member of the Board of Atherioco AB, PetaJoule AB,Cardiovax, the Swedish Research Council and MedScienta AB. He is Professor of Experimental Cardiovascular Research at Lunds Universitet. He was previously, among others, Dean at the Faculty of Medicine at Lunds Universitet between 2000 and 2005 and Assistant Head Secretary with Medicinska forskningsradet (Swedish Medical Research Council) between 1993 and 1996. He holds a Doctorate of Medicine from Karolinska Institutet and a degree in Medicine from Karolinska Institutet.

Jonny Olsson

Mr. Jonny Olsson has been Independent Director of PROBI Aktiebolag since April 23, 2015. He holds Master of Business Administration degree. He is Owner and CEO of Jonny Olsson Consulting AB. He previously held senior positions at Tetra Pak, Oriflame and Ericsson. He is Board Member of The Incredible Journey AB, Ortelius Management, NGI Denmark, Liquid Consulting Inc & AB.